Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2007; 13(16): 2298-2304
Published online Apr 28, 2007. doi: 10.3748/wjg.v13.i16.2298
Published online Apr 28, 2007. doi: 10.3748/wjg.v13.i16.2298
Figure 6 Effects of the SC-236 on pancreatic inflammatory changes following AP.
A: Representative HE-stained sections of pancreas in control rats not given CCK-octapeptide (left panel), in rats given CCK-octapeptide (middle panel), and in rats given SC-236 (right panel). Original magnification × 200; B: Histologic sections of pancreata harvested 12 h after injections of saline (CON), CCK-octapeptide alone, or SC-236-treated groups were scored from 0 (normal) to 3 (severe) for edema, inflammation, vacuolization, and necrosis as described in Materials and Methods. aP < 0.05 vs the saline-treated group.
- Citation: Seo SW, Jung WS, Piao TG, Hong SH, Yun KJ, Park RK, Shin MK, Song HJ, Park SJ. Selective cyclooxygenase-2 inhibitor ameliorates cholecystokinin-octapeptide-induced acute pancreatitis in rats. World J Gastroenterol 2007; 13(16): 2298-2304
- URL: https://www.wjgnet.com/1007-9327/full/v13/i16/2298.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i16.2298